Global Specialty Generics Market Size, Share and Trends Analysis Report, By Type (Injectables and Oral), By Application (Oncology, Inflammatory Conditions, Multiple Sclerosis, and Hepatitis C), By Distribution Channel (Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy), Forecast (2022-2028)

The global specialty generics market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Specialty generics is the generic version of specialty pharmaceutical products. They are one of the most cost-effective when compared with other pharmaceuticals medicines. The rise in the increase rate of chronic diseases, such as cancer, multiple sclerosis, hepatitis C, and others, has led to high demand for specialty generic drugs. Companies are focusing on this market to launch generic versions of the products by developing formulations of the medicines. Due to the low price of generic medicines people prefer to buy it compared to branded medicines. These are driving factor for the global specialty generics market. Other factors such as early patent expirations of essential drugs available in the market and adoption of the off-patent specialty generic as a new entry are boosting demand for the specialty generics during the forecast period.

Some major companies in the market include Teva Pharmaceuticals Industries Ltd., Novartis International AG, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Teva Pharmaceuticals Industries Ltd., Novartis International AG, and Pfizer Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?

Global Specialty Generics Market Report by Segment

By Type

• Injectables
• Oral

By Application

• Oncology
• Inflammatory conditions
• Multiple Sclerosis
• Hepatitis C

By Distribution Channel

• Specialty Pharmacy
• Retail Pharmacy
• Hospital Pharmacy

Global Specialty Generics Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa